ArticleWorld journal of microbiology & biotechnology2026
Construction of engineered Streptomyces albulus by increasing ATP and NADH supply and efficient production of ε-poly-L-lysine from sweet potato powder.
Article in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
ε-Poly-L-lysine (ε-PL), a broad-spectrum and efficient preservative, is widely used in food and pharmaceutical industries. In this study, the construction of engineered Streptomyces albulus by increasing ATP and NADH supply was carried out. Initially, the engineered strain BP3 was constructed by overexpressing pncB, pck, and pdh genes in S. albulus FL21. At 72h, both ATP and NADH levels in BP3 significantly increased compared to the control strain, while NADH/NAD ratio decreased. Consequently, ε-PL production by BP3 reached 1.61 g/L, representing a 30.89% increase over that of the control. Subsequently, when sweet potato powder (SPP) was used as carbon source, ε-PL production by BP3 achieved 1.44 g/L at 100 g/L SPP. Furthermore, transcriptomic analysis indicated that 712 upregulated genes and 743 downregulated genes were identified. Among them, the upregulated genes of asd, nadE and cs related to energy and redox reaction contributed to ε-PL production enhancement. Conversely, downregulation of aspA and gabD genes in competitive pathway redirected metabolic flux toward ε-PL biosynthesis. Finally, the ε-PL production of fed-batch fermentation reached 37.21 g/L and 33.85 g/L using glucose and SPP in a 5-L bioreactor, respectively. In summary, this study provides a valuable reference for the efficient ε-PL production.
Indexed as
Identifiers
42032351What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.